STOCK TITAN

MindMed to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) announced its participation in the Jefferies Global Healthcare Conference in New York from June 8-10, 2022. CEO Robert Barrow will present on June 10, 2022, at 12:45 p.m. ET. The event includes an in-person presentation and one-on-one investor meetings. A webcast of the presentation will be available at this link, with a replay for 90 days on MindMed's website. MindMed focuses on developing treatments for brain health disorders.

Positive
  • None.
Negative
  • None.

NEW YORK, June 1, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that Robert Barrow, Chief Executive Officer and Director, will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY from June 8-10, 2022.

Jefferies Global Healthcare Conference
Format: In-person presentation and scheduled one-on-one investor meetings
Presentation Date: Friday, June 10, 2022
Time: 12:45 p.m. ET
Webcast Link: https://wsw.com/webcast/jeff240/mnmd/1841100

A replay of the webcast will be available in the "News & Media" section of MindMed's website for 90 days following each of the presentations.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media: media@mindmed.co 
For Investors: ir@mindmed.co

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-participate-in-the-jefferies-global-healthcare-conference-301558892.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

When will MindMed participate in the Jefferies Global Healthcare Conference?

MindMed will participate in the Jefferies Global Healthcare Conference from June 8-10, 2022.

Who will represent MindMed at the Jefferies Global Healthcare Conference?

CEO Robert Barrow will represent MindMed at the conference.

What time is MindMed's presentation at the conference?

MindMed's presentation is scheduled for June 10, 2022, at 12:45 p.m. ET.

Where can I watch the MindMed presentation from the Jefferies Conference?

The presentation can be watched via a webcast at this link: https://wsw.com/webcast/jeff240/mnmd/1841100.

How long will the MindMed conference presentation replay be available?

The replay will be available for 90 days following the presentation on MindMed's website.

Mind Medicine (MindMed) Inc. Common Shares

NASDAQ:MNMD

MNMD Rankings

MNMD Latest News

MNMD Stock Data

524.69M
72.48M
1.14%
68.1%
13.61%
Biotechnology
Medicinal Chemicals & Botanical Products
Link
United States of America
NEW YORK